“Maintenance and Improvement of Skin Clearance Response With Brodalumab Among Patients With Moderate-to-Severe Psoriasis” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S23. doi:10.25251/skin.3.supp.23.